Aggarwal Sumit
Insider CIK 1854362 · ELOX President and CEO, Director, 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ELOX Eloxx Pharmaceuticals, Inc | A Award deriv | 2026-06-10 | 2026-06-10 | 328,833 | — | $0 | 328,833 | SEC↗ |
| ELOX Eloxx Pharmaceuticals, Inc | M Exercise deriv | 2026-02-28 | 2026-05-08 | 260,946 | — | $0 | 3,336,144 | SEC↗ |
| ELOX Eloxx Pharmaceuticals, Inc | M Exercise | 2026-02-28 | 2026-05-08 | 260,946 | $0.15 | $39.1K | 1,672,756 | SEC↗ |
| ELOX Eloxx Pharmaceuticals, Inc | M Exercise deriv | 2026-01-24 | 2026-05-08 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ELOX Eloxx Pharmaceuticals, Inc | M Exercise | 2026-01-24 | 2026-05-08 | 15,000 | — | $0 | 1,411,810 | SEC↗ |
| ELOX Eloxx Pharmaceuticals, Inc | A Award deriv | 2025-09-19 | 2026-05-08 | 3,597,090 | — | $0 | 3,597,090 | SEC↗ |
| ELOX Eloxx Pharmaceuticals, Inc | A Award | 2025-09-19 | 2026-05-08 | 1,000,000 | — | $0 | 1,396,810 | SEC↗ |
| ELOX Eloxx Pharmaceuticals, Inc | M Exercise deriv | 2025-08-14 | 2026-05-08 | 42,790 | — | $0 | 0 | SEC↗ |
| ELOX Eloxx Pharmaceuticals, Inc | M Exercise deriv | 2025-08-14 | 2026-05-08 | 25,000 | — | $0 | 0 | SEC↗ |
| ELOX Eloxx Pharmaceuticals, Inc | M Exercise deriv | 2025-08-14 | 2026-05-08 | 68,700 | — | $0 | 0 | SEC↗ |
| ELOX Eloxx Pharmaceuticals, Inc | M Exercise deriv | 2025-08-14 | 2026-05-08 | 60,390 | — | $0 | 0 | SEC↗ |
| ELOX Eloxx Pharmaceuticals, Inc | M Exercise | 2025-08-14 | 2026-05-08 | 196,880 | — | $0 | 396,810 | SEC↗ |
| ELOX Eloxx Pharmaceuticals, Inc | M Exercise deriv | 2025-01-24 | 2025-01-28 | 30,000 | — | $0 | 30,000 | SEC↗ |
| ELOX Eloxx Pharmaceuticals, Inc | M Exercise | 2025-01-24 | 2025-01-28 | 30,000 | — | $0 | 199,930 | SEC↗ |
| ELOX Eloxx Pharmaceuticals, Inc | A Award deriv | 2024-10-16 | 2026-05-08 | 68,700 | — | $0 | 68,700 | SEC↗ |
| ELOX Eloxx Pharmaceuticals, Inc | A Award deriv | 2024-10-16 | 2026-05-08 | 24,810 | — | $0 | 24,810 | SEC↗ |
| ELOX Eloxx Pharmaceuticals, Inc | D To issuer deriv | 2024-10-16 | 2026-05-08 | 24,810 | — | $0 | 0 | SEC↗ |
| ELOX Eloxx Pharmaceuticals, Inc | A Award deriv | 2024-10-16 | 2026-05-08 | 35,580 | — | $0 | 35,580 | SEC↗ |
| ELOX Eloxx Pharmaceuticals, Inc | D To issuer deriv | 2024-10-16 | 2026-05-08 | 35,580 | — | $0 | 0 | SEC↗ |
| ELOX Eloxx Pharmaceuticals, Inc | A Award deriv | 2024-10-16 | 2026-05-08 | 42,790 | — | $0 | 42,790 | SEC↗ |
| ELOX Eloxx Pharmaceuticals, Inc | D To issuer deriv | 2024-10-16 | 2026-05-08 | 42,790 | — | $0 | 0 | SEC↗ |
| ELOX Eloxx Pharmaceuticals, Inc | D To issuer deriv | 2024-10-16 | 2026-05-08 | 68,700 | — | $0 | 0 | SEC↗ |
| ELOX Eloxx Pharmaceuticals, Inc | A Award | 2024-10-16 | 2024-10-17 | 165,000 | — | $0 | 169,930 | SEC↗ |
| ELOX Eloxx Pharmaceuticals, Inc | A Award deriv | 2024-01-24 | 2024-01-26 | 60,000 | — | $0 | 60,000 | SEC↗ |
| ELOX Eloxx Pharmaceuticals, Inc | A Award deriv | 2023-01-25 | 2023-01-27 | 68,700 | — | $0 | 68,700 | SEC↗ |
| ELOX Eloxx Pharmaceuticals, Inc | A Award deriv | 2022-02-06 | 2026-05-08 | 42,790 | — | $0 | 42,790 | SEC↗ |
| ELOX Eloxx Pharmaceuticals, Inc | M Exercise deriv | 2021-12-01 | 2021-12-03 | 279,158 | — | $0 | 0 | SEC↗ |
| ELOX Eloxx Pharmaceuticals, Inc | F Tax w/h | 2021-12-01 | 2021-12-03 | 81,933 | $0.72 | $59.0K | 197,225 | SEC↗ |
| ELOX Eloxx Pharmaceuticals, Inc | M Exercise | 2021-12-01 | 2021-12-03 | 279,158 | — | $0 | 279,158 | SEC↗ |
| ELOX Eloxx Pharmaceuticals, Inc | A Award deriv | 2021-05-18 | 2021-05-18 | 992,409 | — | $0 | 992,409 | SEC↗ |
| ELOX Eloxx Pharmaceuticals, Inc | A Award deriv | 2021-04-01 | 2021-04-02 | 223,304 | — | $0 | 223,304 | SEC↗ |
| ELOX Eloxx Pharmaceuticals, Inc | A Award deriv | 2021-04-01 | 2021-04-02 | 55,854 | — | $0 | 279,158 | SEC↗ |
| ELOX Eloxx Pharmaceuticals, Inc | A Award deriv | 2021-04-01 | 2021-04-02 | 1,423,238 | — | $0 | 1,423,238 | SEC↗ |